GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Jeil Pharma Holdings Inc (XKRX:002620) » Definitions » Cyclically Adjusted PS Ratio

Jeil Pharma Holdings (XKRX:002620) Cyclically Adjusted PS Ratio : 0.13 (As of May. 25, 2024)


View and export this data going back to 1988. Start your Free Trial

What is Jeil Pharma Holdings Cyclically Adjusted PS Ratio?

As of today (2024-05-25), Jeil Pharma Holdings's current share price is ₩10400.00. Jeil Pharma Holdings's Cyclically Adjusted Revenue per Share for the quarter that ended in Mar. 2024 was ₩82,112.40. Jeil Pharma Holdings's Cyclically Adjusted PS Ratio for today is 0.13.

The historical rank and industry rank for Jeil Pharma Holdings's Cyclically Adjusted PS Ratio or its related term are showing as below:

XKRX:002620' s Cyclically Adjusted PS Ratio Range Over the Past 10 Years
Min: 0.08   Med: 0.19   Max: 2.53
Current: 0.13

During the past years, Jeil Pharma Holdings's highest Cyclically Adjusted PS Ratio was 2.53. The lowest was 0.08. And the median was 0.19.

XKRX:002620's Cyclically Adjusted PS Ratio is ranked better than
96.24% of 744 companies
in the Drug Manufacturers industry
Industry Median: 2.115 vs XKRX:002620: 0.13

The Shiller PE Ratio was first used by professor Robert Shiller. He uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings per share of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted PS Ratio. The Cyclically Adjusted Revenue per Share is the average of the inflation adjusted revenue per share of a company over the past 10 years.

Jeil Pharma Holdings's adjusted revenue per share data for the three months ended in Mar. 2024 was ₩12,752.852. Add all the adjusted revenue per share for the past 10 years together and divide 10 will get our Cyclically Adjusted Revenue per Share, which is ₩82,112.40 for the trailing ten years ended in Mar. 2024.

Shiller PE for Stocks: The True Measure of Stock Valuation


Jeil Pharma Holdings Cyclically Adjusted PS Ratio Historical Data

The historical data trend for Jeil Pharma Holdings's Cyclically Adjusted PS Ratio can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Jeil Pharma Holdings Cyclically Adjusted PS Ratio Chart

Jeil Pharma Holdings Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Cyclically Adjusted PS Ratio
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.16 0.21 0.17 0.17 0.14

Jeil Pharma Holdings Quarterly Data
Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
Cyclically Adjusted PS Ratio Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.12 0.14 0.12 0.14 0.13

Competitive Comparison of Jeil Pharma Holdings's Cyclically Adjusted PS Ratio

For the Drug Manufacturers - Specialty & Generic subindustry, Jeil Pharma Holdings's Cyclically Adjusted PS Ratio, along with its competitors' market caps and Cyclically Adjusted PS Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Jeil Pharma Holdings's Cyclically Adjusted PS Ratio Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Jeil Pharma Holdings's Cyclically Adjusted PS Ratio distribution charts can be found below:

* The bar in red indicates where Jeil Pharma Holdings's Cyclically Adjusted PS Ratio falls into.



Jeil Pharma Holdings Cyclically Adjusted PS Ratio Calculation

Like the Shiller PE Ratio, the Cyclically Adjusted PS Ratio takes the Revenue per Share from the past 10 years, adjusts it for inflation, and then calculates the average. This average is then used for the P/S calculation. Because it considers this 10-year average, it's often referred to as the CAPS Ratio.

The Shiller PE Ratio was first used by professor Robert Shiller to measure the valuation of the overall market. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted PS Ratio.

Jeil Pharma Holdings's Cyclically Adjusted PS Ratio for today is calculated as

Cyclically Adjusted PS Ratio=Share Price/ Cyclically Adjusted Revenue per Share
=10400.00/82112.4
=0.13

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Jeil Pharma Holdings's Cyclically Adjusted Revenue per Share for the quarter that ended in Mar. 2024 is calculated as:

For example, Jeil Pharma Holdings's adjusted Revenue per Share data for the three months ended in Mar. 2024 was:

Adj_RevenuePerShare=Revenue per Share/CPI of Mar. 2024 (Change)*Current CPI (Mar. 2024)
=12752.852/118.8477*118.8477
=12,752.852

Current CPI (Mar. 2024) = 118.8477.

Jeil Pharma Holdings Quarterly Data

Revenue per Share CPI Adj_RevenuePerShare
201406 35,227.542 99.353 42,139.768
201409 35,129.736 99.608 41,915.191
201412 33,760.409 99.098 40,488.677
201503 37,692.477 99.720 44,922.425
201506 39,001.899 100.050 46,329.695
201509 94,016.150 100.110 111,613.257
201512 40,583.337 100.220 48,126.484
201603 41,300.760 100.560 48,811.658
201606 2,464.021 100.790 2,905.479
201609 14,909.590 101.460 17,464.720
201612 3,152.640 101.560 3,689.287
201703 51,905.565 102.850 59,979.164
201706 3,061.849 102.610 3,546.377
201709 58.846 103.490 67.579
201712 4,385.942 102.990 5,061.260
201803 3,635.977 104.100 4,151.081
201806 4,030.632 104.130 4,600.320
201809 3,942.733 105.650 4,435.256
201812 6,130.490 104.350 6,982.220
201903 11,489.166 104.490 13,067.863
201906 12,062.304 104.880 13,668.737
201909 11,830.164 105.200 13,364.903
201912 12,029.535 105.120 13,600.481
202003 12,307.783 105.540 13,859.690
202006 12,605.399 104.870 14,285.522
202009 12,332.953 106.200 13,801.724
202012 12,404.846 105.765 13,939.222
202103 12,208.177 107.357 13,514.825
202106 12,502.247 107.579 13,811.885
202109 13,018.250 108.759 14,225.822
202112 12,055.285 109.676 13,063.365
202203 12,726.934 111.806 13,528.519
202206 14,051.691 114.083 14,638.588
202209 12,831.136 114.831 13,279.925
202212 12,276.502 115.200 12,665.204
202303 13,482.037 116.550 13,747.873
202306 12,985.661 117.140 13,174.981
202309 12,687.496 119.111 12,659.428
202312 13,242.702 118.848 13,242.702
202403 12,752.852 118.848 12,752.852

Add all the adjusted revenue per share together and divide 10 will get our Cyclically Adjusted Revenue per Share.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.


Jeil Pharma Holdings  (XKRX:002620) Cyclically Adjusted PS Ratio Explanation

Compared with the regular PS Ratio, which works poorly for cyclical businesses, the Cyclically Adjusted PS Ratio smoothed out the fluctuations of revenue during business cycles. Therefore it is more accurate in reflecting the valuation of the company.

If a company has consistent business performance, the Cyclically Adjusted PS Ratio should give similar results to regular PS Ratio.


Jeil Pharma Holdings Cyclically Adjusted PS Ratio Related Terms

Thank you for viewing the detailed overview of Jeil Pharma Holdings's Cyclically Adjusted PS Ratio provided by GuruFocus.com. Please click on the following links to see related term pages.


Jeil Pharma Holdings (XKRX:002620) Business Description

Traded in Other Exchanges
N/A
Address
745-5, Banpo-dong, Seocho-gu, Seoul, KOR, 137-810
Jeil Pharma Holdings Inc is involved in manufacture and distribution of pharmaceutical products. The company mainly produces finished pharmaceutical products and active pharmaceutical ingredients. It has categorized its products in Antibiotic, Oncology, Cardiovascular, Gastrointestinal, Urology, Respiratory etc. The firm's manufacturing facility and research and development institute located at Yongin-si, Gyeonggi-do in Korea.

Jeil Pharma Holdings (XKRX:002620) Headlines

No Headlines